Attorney-Client Privilege at Risk in FCA Investigations of Healthcare Organizations
Protecting Confidential Information and Work Product, Avoiding Inadvertent Disclosure and Waiver
Course Details
- smart_display Format
On-Demand
- signal_cellular_alt Difficulty Level
- work Practice Area
Health
- event Date
Tuesday, May 16, 2017
- schedule Time
1:00 PM E.T.
- timer Program Length
90 minutes
-
This 90-minute webinar is eligible in most states for 1.5 CLE credits.
-
This CLE course will provide guidance to healthcare counsel for protecting the attorney-client privilege when responding to investigations arising under the False Claims Act (FCA). The panelists will offer their insights into the scope of applicable privileges, how such privileges can be inadvertently waived, and how to best protect these privileges.
Healthcare organizations must protect the confidentiality of sensitive information when providing documents to independent auditors or government investigators. Inadvertently submitting records protected by the attorney-client privilege can result in waiver of the privilege.
The Department of Justice (DOJ) is aggressively enforcing the FCA. Over half of the nearly $5 billion recovered in 2016 came from the healthcare industry. On Mar. 1, 2017, the U.S. District Court for the Middle District of Florida ordered nursing facility operators in an FCA case to pay $347 million (U.S. ex rel. Ruckh v. CMC II L.L.C.). The order followed a jury verdict that found the defendants knowingly submitted false claims to Medicare and Medicaid.
Counsel at both large and small healthcare companies must understand the issues related to preserving and protecting the attorney-client privilege in FCA-related investigations. Our panelists will discuss how counsel can guide a healthcare organization in protecting these privileges during an outside investigation or when conducting an internal investigation.
Listen as our authoritative panel of healthcare attorneys examines recent developments on attorney-client privilege and work product doctrine in healthcare investigations and enforcement. The panel will also address Upjohn issues and the Yates memo, and will offer best practices for preserving and asserting the privilege and work product doctrine.
- Privilege, work product and waiver—recent developments in the healthcare context
- Privilege issues in FCA investigations
- Halifax and its lessons
- Privilege and government investigations
- Upjohn issues and the Yates Memo
- Preserving the privilege
The panel will review these and other key issues:
- What approaches should healthcare organizations and their counsel implement to identify and protect privileged information?
- How can a healthcare organization maintain the confidentiality of sensitive information when conducting an internal investigation or during a government investigation?
- What are the key business and legal best practices for counsel and healthcare organizations to preserve the privilege?
